And more drug company shenanigans

New york times today shows that drug company shenanigans know no bounds (ie, not just in US!!).  Johnson and Johnson seems to have paid off Novartis to keep them from releasing a generic version of fentanyl in the Netherlands.  See link below.  Geoff
 
 

Comments

Post a Comment

if you would like to receive the near-daily emails regularly, please email me at gmodest@uphams.org

Popular posts from this blog

getting rid of vaccines?????

  --as we quickly approach the post-science darkening ages, i thought it would be useful to recirculate an old blog on measles. But first, some comments on the anti-vaxxers and polio:       -- per the NY Times: "The lawyer helping Robert F. Kennedy Jr. pick federal health officials for the incoming Trump administration has petitioned the government to revoke its approval of the polio vaccine, which for decades has protected millions of people  from a virus that can cause paralysis or death…that campaign is just one front in the war that the lawyer, Aaron Siri, is waging against vaccines of all kinds ”: https://www.nytimes.com/2024/12/13/health/aaron-siri-rfk-jr-vaccines.html       --it is abundantly clear that the polio epidemic in the US in the 1950s led to both lots of morbidity and mortality back then, that lots of post-polio muscular problems until now, that the vaccine invented then by Jonas Salk dramatically stemmed the virus...
Read more

Sciatica: acupuncture helps

Image
  a recent study of patients with sciatica from a herniated lumbar disc found that acupuncture vs sham acupuncture was associated with significant improvements in pain and function (see   sciatica acupuncture helps JAMAintmed2024  in dropbox, or doi:10.1001/jamainternmed.2024.5463)   Details : -- 216 participants were randomly assigned to receive 10 sessions of acupuncture (n = 110) or sham acupuncture (n = 110) over 4 weeks, in a multicenter clinical trial conducted in 6 tertiary-level hospitals in China in 2021. all participants had pain for at least 3 months, with at least moderate leg pain intensity of >40mm on the visual analog scale -- mean age 51.3 years; 147 females (68.1%) -- BMI 24, duration of low back pain (LBP) 3 years -- site of MRI- or CT-determined disk disease: L3-4 in 33%, L4-5 in 78%, L5-S1 in 70% -- treatments received: NSAIDs 7%, steroids <1%, neurotropic drugs (mecobalamin, vitamin B1, vitamin B12) 4%, acupuncture 27%, Chinese he...
Read more

UPDATE: ASCVD risk factor critique

I decided to do an extensive update of my prior ASCVD (atherosclerotic cardiovascular disease) risk analysis and critique of risk calculators, with much more information about the “non-traditional” risk factors. I felt that there should be more data/clarification, since I think we are really undertreating/not preventing the most common cause of death by relying on the current ASCVD risk calculators   -- Cardiovascular risk models:      -- many of us rely on the various cardiovascular risk models to determine the appropriate approach to patients, and these are often integrated into the electronic medical records      -- these risk models have several very important limitations:          -- they are typically based on community data, eg from the Framingham study etc. But, in clinical practice, we are dealing with the individual and not the community:          ...
Read more